Starting at $357/month
The most powerful weight loss medication available, backed by clinical science.
Up to 20.9% body weight reduction — greater than any single GLP-1 medication
Targets both GLP-1 and GIP receptors for superior metabolic results
Clinically shown to improve cardiovascular and metabolic markers
Powerful hunger suppression that keeps you on track
Fill out the online medical questionnaire in minutes from your phone.
A licensed provider reviews your history and recommends a personalized treatment plan.
Your prescription is prepared by our accredited pharmacy and shipped in discreet packaging to your door.
Everything you need to know about Compounded Tirzepatide.
Compounded Tirzepatide is a dual GLP-1 and GIP receptor agonist — the same active ingredient found in Mounjaro® and Zepbound®. Its dual-action mechanism produces superior weight loss results compared to single GLP-1 medications.
Clinical trials show Tirzepatide produces up to 20.9% average body weight loss, compared to 16.8% for Semaglutide. Tirzepatide targets two hormone receptors (GLP-1 and GIP), while Semaglutide targets one (GLP-1 only), making Tirzepatide more potent for most patients.
All patients begin at the lowest dose (2.5mg) and titrate upward based on tolerance and response. Your provider will guide your dosing schedule.
Tirzepatide is ideal for patients who want the most powerful weight loss results and are committed to a structured program. Your licensed provider will evaluate your health history during your telehealth consultation to determine if it's appropriate for you.